Dr. Jean-Francois Grenier is a seasoned executive from the bio-pharmaceutical industry. Trained as a Medical Doctor in Canada, he also earned a graduate diploma in Business Administration.
Jean-Francois occupied leading positions in drug development, marketing and general management with Bristol-Myers Squibb, Schering AG and Bayer, in North America, Asia and Europe.
Mr. Jacques Bourjot is an Engeneer,who graduated from “Arts & Métiers”.
He has dedicated large parts of his professional life to community building projects with leading construction firms like as Screg and Eiffage.
Through his experience in those people-oriented and community projects, Jacques developed an extensive network with decision-makers in the North of France as well as with investors.
As a leading Business Angel in the Lille area and with Arts & Métiers Business Angels, Mr. Bourjot support numbers of startup companies, which enjoy his management experience and networking expertise.
Mr. Guillaume Bruniaux is Project Director at « Nord France Amorçage » or « NFA », a Public Investment Capital fund of « Région Hauts-de-France ».
NFA, which is managed by Siparex, a pioneer in Investment Capital in France.
NFA is committed to co-investing in high-potential startups of the Region at the seeding stage.
With more than15 years of experience gained with Cerfrance, the Chamber of Commerce and Siparex, Guillaume supports and advises managers of more than twenty startup companies in the North of France, many of which operate in health and health-related area.
Mr. Hervé Vanderhaegen is a Private Equity manager since 1991.He is currently board member of IRD Gestion, a leading actor in the economic development of “Hauts de France”.
Hervé is also Nord Creation’s Operational Manager, an investment fund, which has been helping more than 400 companies with high development potential for the last 25 years.
Beyond financing, Nord Creation’s philosophy is to actively support CEOs of invested startup companies, accelerate their development and transform them into successful SMEs.
Dr. Elisabeth Baumelou-Torck is a physician specialized in hematology and oncology with extensive clinical and research experience.
Dr. Baumelou-Torck founded the Hemato-Oncology Department of Foch Hospital in Paris area and served as Associate Manager until 2000.
In Lille (North of France), she has coordinated a research network with the Regional University Hospital (the largest University Hospital in Europe), before founding and leading the Catholic Hospitals Research Council.
Along her clinical and research activities, Elisabeth has been extensively involved with the French High Health Authority and National Drug Agency in different managing functions and expert capacities.
Medical Expert in the Public Health & Post-Approval Research Working Group
